Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Capecitabine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover a novel mild process for Capecitabine synthesis from Furtulon. High purity, scalable route offering significant cost reduction in pharmaceutical manufacturing.
Patent CN102993253B reveals a reusable polymer-supported catalyst method for synthesizing capecitabine intermediates, offering significant supply chain stability and cost reduction in pharmaceutical manufacturing.
Patent CN103601777A details a high-purity capecitabine preparation method using isopropyl ether crystallization, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.
Optimized three-step synthesis for Capecitabine API ensures high purity and industrial scalability for global pharmaceutical supply chains and cost reduction.
Patent CN102382160B details a green capecitabine route using manganese chloride. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel amidation-first route for Capecitabine synthesis improves yield to 68% and purity. Cost-effective supply chain solution for oncology APIs.
Solve capecitabine production challenges with non-toxic alkoxycarbonylation. Avoid phosgene, reduce EHS risks, and achieve >80% yields for stable supply chains.